Proliferative diabetic retinopathy in patients with type 2 diabetes correlates with the presence of atherosclerosis cardiovascular disease

被引:11
|
作者
Gao, Lu [1 ]
Zhao, Wei [1 ]
Yang, Jin-Kui [2 ]
Qin, Ming-Zhao [1 ]
机构
[1] Capital Med Univ, Beijing Tongren Hosp, Dept Geriatr, Beijing 100730, Peoples R China
[2] Capital Med Univ, Beijing Tongren Hosp, Dept Endocrinol, Beijing, Peoples R China
来源
DIABETOLOGY & METABOLIC SYNDROME | 2021年 / 13卷 / 01期
关键词
HEART-DISEASE; RISK-FACTORS; CHINESE; MORTALITY; EVENTS; COMPLICATIONS; PREVALENCE; RESTENOSIS; SEVERITY; SYSTEM;
D O I
10.1186/s13098-021-00666-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Atherosclerosis cardiovascular disease (ASCVD) is the main cause of morbidity and mortality in type 2 diabetes mellitus (T2DM). As most diabetic patients with ASCVD are asymptomatic, it is most neglected in clinical practice. For this reason, identifying high-risk ASCVD population with intensified treatment is very important. In recent years, the relationship between diabetic retinopathy (DR) and ASCVD has caused much academic concern, but the results are inconsistent. Moreover, whether all grades of DR increase the risk of ASCVD remains controversial. Most importantly, very few data can be found in China. Objective Our aim is to discuss whether all grades of DR increase the risk of ASCVD after adjustment for the traditional cardiovascular risk factors and to assess the independent contribution of DR to cardiovascular events in patients with T2DM, hoping to provide more evidence for early identification of ASCVD. Research design and methods A total of 425 T2DM patients with complete physical and biochemical data were included in the study. The grade of DR was assessed with two 45 color digital retinal images. Based on the presence of history of ASCVD, 425 T2DM patients were divided into 2 groups: ASCVD group and non-ASCVD group. Results ASCVD patients were older and had a significantly higher fasting plasma glucose (FPG) and glycated haemoglobin (HbA1c) and proportion of history of ASCVD. At the same time, they were more likely to be females, and had lower level of alcohol and calculated glomerular filtration rate (eGFR) than non-ASCVD patients. Their trend to develop DR with ASCVD was significantly higher than patients with non-ASCVD (chi(2) = 5.805, P = 0.016). DR was an independent statistical indicator of the presence of ASCVD [odds ratio (OR) (95% CI): 2.321 (1.152-4.678), P = 0.018]. Furthermore, when DR was divided into non-proliferative retinopathy (NPDR) and proliferative retinopathy (PDR) according to its severity, only PDR was significantly associated with incident ASCVD [OR (95% CI): 8.333 (1.813-38.304), P = 0.006]. After adjusting for traditional ASCVD risk factors, such an association still existed [OR (95% CI): 7.466 (1.355-41.137), P = 0.021]. Conclusion DR associates strongly with ASCVD in the Chinese population with T2DM. With the increasing severity of DR, the risk of ASCVD also increases. After adjustment for traditional risk factors, PDR is still an independent risk marker for ASCVD.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Diabetic retinopathy is associated with the presence and burden of subclinical carotid atherosclerosis in type 1 diabetes
    Marc Carbonell
    Esmeralda Castelblanco
    Xavier Valldeperas
    Àngels Betriu
    Alícia Traveset
    Minerva Granado-Casas
    Marta Hernández
    Federico Vázquez
    Mariona Martín
    Esther Rubinat
    Albert Lecube
    Josep Franch-Nadal
    Elvira Fernández
    Manel Puig-Domingo
    Angelo Avogaro
    Núria Alonso
    Dídac Mauricio
    Cardiovascular Diabetology, 17
  • [22] Risk factors for prevalent diabetic retinopathy and proliferative diabetic retinopathy in type 1 diabetes
    Laiginhas, Rita
    Madeira, Carolina
    Lopes, Miguel
    Neves, Joao Sergio
    Barbosa, Margarida
    Rosas, Vitor
    Carvalho, Davide
    Falcao-Reis, Fernando
    Falcao, Manuel
    ENDOCRINE, 2019, 66 (02) : 201 - 209
  • [23] Diabetic retinopathy is associated with the presence and burden of subclinical carotid atherosclerosis in type 1 diabetes
    Carbonell, Marc
    Castelblanco, Esmeralda
    Valldeperas, Xavier
    Betriu, Angels
    Traveset, Alicia
    Granado-Casas, Minerva
    Hernandez, Marta
    Vazquez, Federico
    Martin, Mariona
    Rubinat, Esther
    Lecube, Albert
    Franch-Nadal, Josep
    Fernandez, Elvira
    Puig-Domingo, Manel
    Avogaro, Angelo
    Alonso, Nuria
    Mauricio, Didac
    CARDIOVASCULAR DIABETOLOGY, 2018, 17
  • [24] Risk factors for prevalent diabetic retinopathy and proliferative diabetic retinopathy in type 1 diabetes
    Rita Laiginhas
    Carolina Madeira
    Miguel Lopes
    João Sérgio Neves
    Margarida Barbosa
    Vitor Rosas
    Davide Carvalho
    Fernando Falcão-Reis
    Manuel Falcão
    Endocrine, 2019, 66 : 201 - 209
  • [25] Commentary : Vitrectomy for proliferative diabetic retinopathy in patients with type 1 diabetes mellitus
    Tekchandani, Uday
    Dogra, Mohit
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2021, 69 (11) : 3296 - 3296
  • [26] Relationship between Microalbuminuria and Subclinical Atherosclerosis According to the Presence of Diabetic Retinopathy in Korean Type 2 Diabetic Patients
    Chung, Min Young
    Chung, Jin Ook
    Cho, Dong Hyeok
    Chung, Dong Jin
    DIABETES, 2010, 59 : A235 - A235
  • [27] Microalbuminuria as a risk factor for proliferative diabetic retinopathy in type 2 diabetic patients
    Boelter, MC
    Moreira, JSR
    Triches, CB
    Neto, AFPR
    Copstein, E
    Lavinsky, J
    Gross, JL
    Azevedo, MJ
    DIABETES, 2001, 50 : A472 - A472
  • [28] Diabetic Retinopathy as a Predictor of Angiographic Coronary Atherosclerosis Severity in Patients with Type 2 Diabetes Mellitus
    Eid, Mohamed
    Mounir, Amr
    El Etriby, Shehab
    Al Taher, Ali
    Ezzat, Mohamed A. W.
    DIABETES METABOLIC SYNDROME AND OBESITY, 2022, 15 : 1485 - 1494
  • [29] Risk Factors for Proliferative Diabetic Retinopathy in African Americans with Type 2 Diabetes
    Penman, Alan
    Hancock, Heather
    Papavasileiou, Evangelia
    James, Maurice
    Idowu, Omolola
    Riche, Daniel M.
    Fernandez, Marlene
    Brauner, Stacey
    Smith, Sataria O.
    Hoadley, Suzanne
    Richardson, Cole
    Vazquez, Vanessa
    Chi, Cheryl
    Andreoli, Christopher
    Husain, Deeba
    Chen, Ching J.
    Sobrin, Lucia
    OPHTHALMIC EPIDEMIOLOGY, 2016, 23 (02) : 88 - 93
  • [30] A Retrospective Analysis for Progression to Proliferative Diabetic Retinopathy (PDR) in Type 2 Diabetes
    Bhandari, R.
    Reich, I.
    Frisbee, J.
    Kartvelishvili, A.
    Coe, R.
    Hajee, M. E.
    Shrier, E. M.
    Lazzaro, D. R.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)